Riskpilot← Back to searchSign inGet full accessStrom Neurology AB
ABActiveOrg 5593528580Lövängsvägen 5 BOther education n.e.c. · NACE 8559Est. 20210 employees
Revenue 2025
SEK 239K
+9% vs 2024
EBITDA margin
38.7%
-35% vs 2024
Equity ratio
77.6%
Financial strength
Net profit 2025
SEK 73K
-37% vs 2024
| Revenue | SEK 239K | +9% |
| EBITDA | SEK 93K | -35% |
| Net profit | SEK 73K | -37% |
| Total assets | SEK 132K | -47% |
| Equity | SEK 102K | -40% |
| Employees | 0 | — |
Legal name
Strom Neurology AB
Org number
5593528580
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
13 december 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolagets verksamhet ska vara att sälja kurser inom sjukvård och forskning, samt att sälja konsulttjänster inom samma område.
Address
Lövängsvägen 5 B
Email
jakob.o.strom@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 222 | 282 | 219 | 239 |
| Staff expenses | — | — | — | −0 |
| EBITDA | 138 | 210 | 142 | 93 |
| Depreciation & amort. | — | −0 | — | — |
| EBIT | 138 | 210 | 142 | 93 |
| Net financials | 0 | 3 | 3 | −0 |
| Profit before tax | 138 | 213 | 146 | 92 |
| Tax | −28 | −44 | −30 | −19 |
| Net profit | 109 | 169 | 116 | 73 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 194 | 320 | 249 | 132 |
| Equity | 134 | 204 | 169 | 102 |
| Long-term debt | — | 0 | — | — |
| Short-term debt | 59 | 117 | 80 | 29 |
| Total debt | 59 | 117 | 80 | 29 |
EBITDA margin
38.7%
This company
15.8%
Market median
+145% vs market
20222025
Equity ratio
77.6%
This company
38.2%
Market median
+103% vs market
20222025
Return on equity
71.2%
This company
18.4%
Market median
+287% vs market
20222025
Net profit margin
30.5%
This company
8.1%
Market median
+277% vs market
20222025
Asset turnover
1.81×
This company
1.12×
Market median
+62% vs market
20222025
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-13 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
RI Authorized Recipient of Service | Authorized Recipient of Service | 2024 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Strom Neurology AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Runa I Baianstovu | Authorized Recipient of Service | 0 companies |
| Jakob Ola Baianstovu Ström | Board of Directors | 0 companies |
| Karin Maria Eriksson Ström | Deputy Board Member | 0 companies |